[达卡巴嗪（DTIC）治疗与布加综合征]

[Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].

作者信息

Balda B R, Bassermann R

出版信息

MMW Munch Med Wochenschr. 1980 May 23;122(21):792-4.

Abstract

A case of a 58 years old female is presented, who died because of a Budd-Chiari-syndrome. This complication had developed during treatment with Dacarbazine (DTIC), which was given after surgical removal of a malignant melanoma. The causative relation between the Budd-Chiari-syndrome and this cytostatic drug is discussed, even though the influence of other drugs cannot be excluded.

摘要

报告一例58岁女性病例，该患者因布加综合征死亡。此并发症发生在手术切除恶性黑色素瘤后使用达卡巴嗪（DTIC）治疗期间。文中讨论了布加综合征与这种细胞毒性药物之间的因果关系，尽管不能排除其他药物的影响。